a
toxicity study of Sutherlandia leaf powder (sutherlandia
microphylla) consumption
Sutherlandia microphylla
Complete
study
(pdf format, 273 kb)
to download, right-click and save file
The
study is also available in four sections
Study
details and results - pages 1-13 (pdf format 86kb)
Appendix
I-Haematology results - pages 14-20 (pdf format 251kb)
Appendix
II-Biochemistry results - pages 21-31 (pdf format 396kb)
Appendix
III-Physiology results - pages 32-35 (pdf format 135kb)
Contact
person: Dr Gilbert Matsabisa, MRC
E-mail: motlalepula.matsabisa@mrc.ac.za
Tel: Tel: +27 21 938-0480
1. Main
objective
2. Ethics
3. Abbreviations
4. Materials and Methods
4.1. Nonhuman primates, environment and housing
4.2. Treatments
4.2.1. Plant material
4.2.2. Dose
4.2.3. Duration of treatments
4.3. Administration of Sutherlandia leaf powder
4.4. Dosing schedule
4.5. Clinical monitoring
3.6. Observations
3.7. Statistics
5.0. Results
5.1. Preliminary considerations
5.2. Compliance
5.3. General observations
5.4. Haematology
5.5. Biochemistry
5.6. Physiological variables 8
5.7 . Urine analysis 9
6.0. Conclusions 12
Unit abbreviation
for appendices I – III 13
Appendix I : Haematology
Appendix II: Biochemistry
Appendix III: Physical and physiological variables
The
study was jointly financed by the
Medical
Research Council (MRC) and
a research grant from the National
Research Foundation (NRF).
|
